MFZ10-7

Details

Stereochemistry	ACHIRAL
Molecular Formula	C15H9FN2
Molecular Weight	236.2438
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CC1=NC(=CC=C1)C#CC2=CC(F)=CC(=C2)C#N

InChI

InChIKey=ZGEXQIMQZVRTDZ-UHFFFAOYSA-N

InChI=1S/C15H9FN2/c1-11-3-2-4-15(18-11)6-5-12-7-13(10-17)9-14(16)8-12/h2-4,7-9H,1H3

HIDE SMILES / InChI

Molecular Formula	C15H9FN2
Molecular Weight	236.2438
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249

MFZ 10-7 is a high affinity negative allosteric modulator at the mGlu5 receptor (Ki = 0.67 nM). MFZ 10-7 demonstrates anxyolitic properties in mouse models. Intraperitoneal administration of MFZ 10-7 inhibited intravenous cocaine self-administration, cocaine-induced reinstatement of drug-seeking behavior and cocaine-associated cue-induced cocaine-seeking behavior in rats.

CNS Activity

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Metabotropic glutamate receptor 5 40 Target ID: P41594 Gene ID: 2915.0 Gene Symbol: GRM5 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249	Antagonist 2849		1.22 nM [IC50]

Conditions

Condition	Modality	Targets	Highest Phase	Product
Anxiety 275 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21546249	Primary		Preclinical	Unknown Approved Use Unknown
Cocaine addiction 29 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24001208	Primary		Preclinical	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
A novel mGluR5 antagonist, MFZ 10-7, inhibits cocaine-taking and cocaine-seeking behavior in rats.	2014-03	24001208
Metabotropic glutamate receptor 5 negative allosteric modulators as novel tools for in vivo investigation.	2012-07-12	22924094
Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series.	2011-06-01	21546249

Patents

Sample Use Guides

In Vivo Use Guide

For anxyolitic tests MFZ 10-7 was delivered via ip injection 15 min prior to testing. Anxyolitic effects were observed at dose 0.3 mg/kg.

Route of Administration: Intraperitoneal

In Vitro Use Guide

MFZ 10-7 was evaluated for antagonism of glutamate-mediated mobilization of internal calcium in an mGluR5 in vitro assay. MFZ 10-7 (compound 2d) inhibited mGluR5 with IC50 1.22 nM.

Substance Class	Chemical Created by `admin` on `Wed Apr 02 09:20:05 GMT 2025` Edited by `admin` on `Wed Apr 02 09:20:05 GMT 2025`
Record UNII	FV36HKQ9RA
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

MFZ10-7

Code

English

MFZ-10-7

Preferred Name

English

3-Fluoro-5-[2-(6-methyl-2-pyridinyl)ethynyl]benzonitrile

Systematic Name

English

Benzonitrile, 3-fluoro-5-[2-(6-methyl-2-pyridinyl)ethynyl]-

Systematic Name

English

Code System Code Type Description

CAS

1224431-15-5